|
1
|
Gordts S, Koninckx P and Brosens I:
Pathogenesis of deep endometriosis. Fertil Steril. 108:872–885.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Czyzyk A, Podfigurna A, Szeliga A and
Meczekalski B: Update on endometriosis pathogenesis. Minerva
Ginecol. 69:447–461. 2017.PubMed/NCBI
|
|
3
|
Li J, Ma J, Fei X, Zhang T, Zhou J and Lin
J: Roles of cell migration and invasion mediated by twist in
endometriosis. J Obstet Gynaecol Res. 45:1488–1496. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kodaman PH: Current strategies for
endometriosis management. Obstet Gynecol Clin North Am. 42:87–101.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Grimstad FW and Carey E: Periclitoral
endometriosis: The dilemma of a chronic disease invading a rare
location. J Minim Invasive Gynecol. 22:684–686. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jin Y, Khadka DB and Cho WJ:
Pharmacological effects of berberine and its derivatives: A patent
update. Expert Opin Ther Pat. 26:229–243. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu L, Fan J, Ai G, Liu J, Luo N, Li C and
Cheng Z: Berberine in combination with cisplatin induces
necroptosis and apoptosis in ovarian cancer cells. Biol Res.
52:372019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Du J, Sun Y, Lu YY, Lau E, Zhao M, Zhou QM
and Su SB: Berberine and evodiamine act synergistically against
human breast cancer MCF-7 cells by inducing cell cycle arrest and
apoptosis. Anticancer Res. 37:6141–6151. 2017.PubMed/NCBI
|
|
9
|
Abrams SL, Follo MY, Steelman LS,
Lertpiriyapong K, Cocco L, Ratti S, Martelli AM, Candido S, Libra
M, Murata RM, et al: Abilities of berberine and chemically modified
berberines to inhibit proliferation of pancreatic cancer cells. Adv
Biol Regul. 71:172–182. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang Y and Zhang S: Berberine suppresses
growth and metastasis of endometrial cancer cells via
miR-101/COX-2. Biomed Pharmacother. 103:1287–1293. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jin P, Zhang C and Li N: Berberine
exhibits antitumor effects in human ovarian cancer cells.
Anticancer Agents Med Chem. 15:511–516. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wu G, Zheng H, Xu J, Guo Y, Zheng G, Ma C,
Hao S, Liu X, Chen H, Wei S, et al: miR-429 suppresses cell growth
and induces apoptosis of human thyroid cancer cell by targeting
ZEB1. Artif Cells Nanomed Biotechnol. 47:548–554. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dai W, He J, Zheng L, Bi M, Hu F, Chen M,
Niu H, Yang J, Luo Y, Tang W and Sheng M: miR-148b-3p, miR-190b,
and miR-429 regulate cell progression and act as potential
biomarkers for breast cancer. J Breast Cancer. 22:219–236. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Han Y, Zhao Q, Zhou J and Shi R: miR-429
mediates tumor growth and metastasis in colorectal cancer. Am J
Cancer Res. 7:218–233. 2017.PubMed/NCBI
|
|
15
|
Liu H, Huang C, Wu L and Wen B: Effect of
evodiamine and berberine on miR-429 as an oncogene in human
colorectal cancer. Onco Targets Ther. 9:4121–4127. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Braicu OL, Budisan L, Buiga R, Jurj A,
Achimas-Cadariu P, Pop LA, Braicu C, Irimie A and Berindan-Neagoe
I: miRNA expression profiling in formalin-fixed paraffin-embedded
endometriosis and ovarian cancer samples. Onco Targets Ther.
10:4225–4238. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Meng X, Liu J, Wang H, Chen P and Wang D:
MicroRNA-126-5p downregulates BCAR3 expression to promote cell
migration and invasion in endometriosis. Mol Cell Endocrinol.
494:1104862019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Garcia-Solares J, Dolmans MM, Squifflet
JL, Donnez J and Donnez O: Invasion of human deep nodular
endometriotic lesions is associated with collective cell migration
and nerve development. Fertil Steril. 110:1318–1327. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shimada H, Satohisa S, Kohno T, Takahashi
S, Hatakeyama T, Konno T, Tsujiwaki M, Saito T and Kojima T: The
roles of tricellular tight junction protein lipolysis-stimulated
lipoprotein receptor in malignancy of human endometrial cancer
cells. Oncotarget. 7:27735–27752. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kim JJ, Kurita T and Bulun SE:
Progesterone action in endometrial cancer, endometriosis, uterine
fibroids, and breast cancer. Endocr Rev. 34:130–162. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen JJ, Xiao ZJ, Meng X, Wang Y, Yu MK,
Huang WQ, Sun X, Chen H, Duan YG, Jiang X, et al: MRP4 sustains
Wnt/β-catenin signaling for pregnancy, endometriosis and
endometrial cancer. Theranostics. 9:5049–5064. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kajiyama H, Suzuki S, Yoshihara M,
Tamauchi S, Yoshikawa N, Niimi K, Shibata K and Kikkawa F:
Endometriosis and cancer. Free Radic Biol Med. 133:186–192. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
McCubrey JA, Lertpiriyapong K, Steelman
LS, Abrams SL, Yang LV, Murata RM, Rosalen PL, Scalisi A, Neri LM,
Cocco L, et al: Effects of resveratrol, curcumin, berberine and
other nutraceuticals on aging, cancer development, cancer stem
cells and microRNAs. Aging (Albany NY). 9:1477–1536. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Dai W, Mu L, Cui Y, Li Y, Chen P, Xie H
and Wang X: Berberine promotes apoptosis of colorectal cancer via
regulation of the long non-coding RNA (lncRNA) cancer
susceptibility candidate 2 (CASC2)/AU-binding factor 1
(AUF1)/B-cell CLL/lymphoma 2 (Bcl-2) axis. Med Sci Monit.
25:730–738. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lo SN, Wang CW, Chen YS, Huang CC, Wu TS,
Li LA, Lee IJ and Ueng YF: Berberine activates aryl hydrocarbon
receptor but suppresses CYP1A1 induction through miR-21-3p
stimulation in MCF-7 breast cancer cells. Molecules. 22:18472017.
View Article : Google Scholar
|
|
27
|
Gao H, Sun X, Wang H and Zheng Y: Long
noncoding RNA SNHG22 increases ZEB1 expression via competitive
binding with microRNA-429 to promote the malignant development of
papillary thyroid cancer. Cell Cycle. 19:1186–1199. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cava C, Novello C, Martelli C, Lodico A,
Ottobrini L, Piccotti F, Truffi M, Corsi F, Bertoli G and
Castiglioni I: Theranostic application of miR-429 in HER2+ breast
cancer. Theranostics. 10:50–61. 2020. View Article : Google Scholar : PubMed/NCBI
|
